Clinical Trials Directory

Trials / Completed

CompletedNCT04948502

SaExten Vena Cava Filter System in Prevention of Pulmonary Embolism

A Multicenter, Randomized, Positive-controlled Clinical Trial to Verify the Efficacy and Safety of the SaExten Vena Cava Filter System in Prevention of Pulmonary Embolism

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
192 (actual)
Sponsor
ShenZhen KYD Biomedical Technology Co., Ltd. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of SaExten vena cava filter (VCF) system (ShenZhen KYD BioTech Co., Ltd., China) in prevention of pulmonary embolism (PE). This is a prospective, multicenter, randomized controlled, positive-controlled clinical trial, which will enroll 204 participants in total. Participants will undergo interventions with SaExten VCF System or Denali filter (C. R. BARD, Inc., USA).

Detailed description

The purpose of this study is to evaluate the efficacy and safety of SaExten vena cava filter (VCF) system in prevention of pulmonary embolism (PE). This is a prospective, multicenter, randomized controlled, positive-controlled clinical trial, which will enroll 204 participants in total, with 102 in each group. Participants will undergo interventions with SaExten VCF System or Denali filter, and be followed up to 12 months if the implantation is permanent, to evaluate the efficacy and safety of SaExten VCF System in prevention of PE.

Conditions

Interventions

TypeNameDescription
DEVICESaExten vena cava filter systemSubjects will undergo intervention, be implanted with a SaExten filter. The filter will be retrieved within 90 days or indwelled permanently, depending on the existence of thrombosis and the evaluation of the physician.
DEVICEDenali inferior vena cava filterSubjects will undergo intervention, be implanted with a Denali filter. The filter will be retrieved within 90 days or indwelled permanently, depending on the existence of thrombosis and the evaluation of the physician.

Timeline

Start date
2020-08-13
Primary completion
2022-01-20
Completion
2022-09-08
First posted
2021-07-02
Last updated
2023-09-29

Locations

16 sites across 1 country: China

Source: ClinicalTrials.gov record NCT04948502. Inclusion in this directory is not an endorsement.